SARRP Mediated Focal Radiotherapy of Triple-Negative Breast Cancer

In the study, Radiotherapy-exposed CD8+ and CD4+ Neoantigens Enhance Tumor Control, SARRP enabled researchers to verify that radiotherapy works in concert with neoantigen vaccination to improve tumor control.

See more below, and the full study here.

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts

OUR COMPANY

RECENT NEWS

XBeam from Xstrahl Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance for Use in the U.S.

Dual Modality Treatment Solution for Dermatologists to be Featured at ASMS Annual Meeting in Houston

Xstrahl to Attend VCS and ASDS Conferences in Orlando

Join Our Newsletter

SARRP Mediated Focal Radiotherapy of Triple-Negative Breast Cancer

Share

Share

Find out more about how Xstrahl will work tirelessly for you

Explore Related Posts

Xstrahl Presented at the 11th Congress of Radiological Technologists of R. N. Macedonia

Xstrahl to Spotlight Superficial and Orthovoltage Radiotherapy Solutions for Skin Cancer and Benign Conditions at ASTRO 2024

Xstrahl to Feature SmART-RAD at RRS 2024 in Tucson, AZ